Simulations Plus, Inc.

NASDAQ:SLP

Medical - Healthcare Information Services

Healthcare
$18.50 +0.11%

+$0.02 today

Market cap
$374.16M
Beta
1.32
P/E (TTM)
-5.9
EPS (TTM)
-$3.12
52W Low $11.09High $21.01

Volume 0.00M

Average 0.35M

SLP Other Non-Cash Items

Other non-cash adjustments that reconcile net income to operating cash flow.

Simulations Plus, Inc.NASDAQ: SLP

Other Non-Cash Items · Q2 FY2026 · quarter ended Feb 2026

Other non-cash items turns positive

Q2 FY2026 other non-cash items was $11K, compared with -$915K a year earlier. Trailing-twelve-month other non-cash items was $77.36M. Over 3 fiscal years it compounded at +255.6% a year.

Context

  • Other non-cash items amounted to 96.4% of revenue in FY2025, up 92.3 pp from a year earlier.
  • Other non-cash items increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly other non-cash items holds near $11K or moves back toward the trailing-twelve-month quarterly average of $19.34M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterFeb 2026
$11K-84.1% QoQ
Last fiscal yearAug 2025
$76.29M+2767.5% YoY
LTMFeb 2026
$77.36M+2527.5% YoY
Other Non-Cash Items past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+101.2%——
1 year+2767.5%——
3-year CAGR+255.6%——
5-year CAGR——
10-year CAGR——

Other Non-Cash Items history

USD · from the cash flow

Latest · FY2025
76.29M USD
Year-over-year change
+2767.5%
4-year CAGR
+129.8%

Other Non-Cash Items vs competitors

How SLP compares with its peers on the latest reported figures

  • Peers report in different currencies, so other non-cash items is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +2527.5% is the 3rd highest of 11, against a peer median of +44.6%.
  • Other non-cash items amounts to 96.1% of revenue for SLP, versus a peer median of 17.0%.
SLP Competitors
Other Non-Cash Items for SLP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
NAKANakamoto Inc.LTM Mar 2026$249.6M USD+38874.3%+917.6%6367.8%
DHDefinitive Healthcare Corp.LTM Mar 2026$141.16M USD-81.1%+143.0%59.2%
SLPSimulations Plus, Inc.LTM Feb 2026$77.36M USD+2527.5%+255.6%96.1%
KRROKorro Bio, Inc.LTM Mar 2026$35.13M USD+6869.2%+175.6%914.2%
CLLSCellectis S.A.LTM Mar 2026$19.72M USD+30.1%—29.0%
AGLAgilon Health, Inc.LTM Mar 2026$17.5M USD+497.5%—0.3%
SOPHSOPHiA GENETICS S.A.LTM Mar 2026$12.65M USD+342.8%+187.5%15.6%
ANROAlto Neuroscience, Inc.LTM Mar 2026$4.01M USD+59.1%+61.6%—
OPRXOptimizeRx CorporationLTM Mar 2026$775K USD-94.7%-10.1%0.7%
ACIUAC Immune S.A.LTM Dec 2025CHF 606.88K CHF-74.7%—17.0%
NRCNational Research CorporationLTM Mar 2026$255K USD+9.4%-40.4%0.2%
Peer median (excluding SLP) —+44.6%+143.0%17.0%

Competitors are the stored peer set for SLP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Aug 2023
FY2024
Aug 2024
FY2025
Aug 2025
Net Income9.78M12.48M9.96M9.95M(64.72M)
Depreciation & Amortization3.59M3.57M3.84M5.67M8.21M
Deferred Income Tax(628K)(270K)(2.1M)(1.77M)(5.43M)
Stock-Based Compensation2.75M3.04M4.83M6.54M6.35M
Change in Working Capital974K(2.62M)5.1M(4.21M)(2.59M)
Accounts Receivables(2.43M)(3.94M)4.1M3.13M(581K)
Inventory3.15M0000
Accounts Payables39K(162K)(81K)(477K)(132K)
Other Working Capital210K1.48M1.09M(6.86M)(1.87M)
Other Non-Cash Items2.74M1.7M219K(2.86M)76.29M
Operating Cash Flow19.2M17.9M21.86M13.32M18.13M
Capital Expenditures(4.58M)(3.97M)(4.27M)(566K)(713K)
Acquisitions (Net)2.95M3.15M(8.22M)(98.77M)0
Purchases of Investments(122.4M)(100.85M)(95.05M)(67.16M)(6.5M)
Sales of Investments100.23M109.12M114.91M116.27M15.01M
Other Investing Activities(2.95M)(3.15M)(3.82M)(3.74M)(4.24M)
Investing Cash Flow(26.74M)4.31M7.37M(53.97M)3.56M
Debt Repayment00000
Common Stock Issued1.46M891K0731K430K
Common Stock Repurchased00(20M)00
Dividends Paid(4.81M)(4.85M)(4.81M)(4.8M)0
Other Financing Activities(1.33M)(3.67M)1.54M(2.5M)(1.58M)
Financing Cash Flow(4.68M)(7.62M)(23.27M)(6.57M)(1.15M)
Effect of Forex Changes00000
Net Change in Cash(12.22M)14.58M5.96M(47.21M)20.54M
Free Cash Flow14.63M13.93M17.58M12.75M17.41M

Simulations Plus, Inc.

NASDAQ:SLP

Intrinsic Alpha fair value

Locked

Current Price

$18.50

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.